Vendor Intelligence Report: Tianjin Eleli Technology Development

Published 3 Jul 2026. 21-page investigative report on who is behind Tianjin Eleli Technology Development: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Across 19 Finnrick lab tests, Tianjin Eleli posts a 53% overall pass rate, with Retatrutide the relative bright spot but compromised by a documented no-Retatrutide vial; GHK-Cu and Tirzepatide are…